Trial intelligence / Profile preview

TPF vs PF Induction Chemotherapy in Locally Advanced SCCHN

NCT00273546Phase 3Completed

Sponsor
Sanofi
Start
May 1999
Primary completion
Feb 2006
Modality
Small Molecules
Countries
6
01

Overview

A Phase 3 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sanofi. Started May 1999; status: completed.

02

Drugs

docetaxel
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT00273546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00273546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call